B
79.91
1.76 (2.25%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | BridgeBio Pharma, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
-1.0
| 分析师共识 | -0.5 |
| 内部交易活动 | NA |
| 价格波动 | -3.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | -1.00 |
|
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 4.97% |
| 机构持股比例 | 98.14% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Aisling Capital Management Lp | 30 Sep 2025 | 6,089,611 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 110.00 (Cantor Fitzgerald, 37.66%) | 购买 |
| 中 | 92.00 (15.13%) | |
| 低 | 71.00 (Raymond James, -11.15%) | 购买 |
| 平均值 | 90.92 (13.78%) | |
| 总计 | 12 购买 | |
| 平均价格@调整类型 | 67.79 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wells Fargo | 20 Jan 2026 | 88.00 (10.12%) | 购买 | 77.19 |
| 11 Nov 2025 | 84.00 (5.12%) | 购买 | 66.58 | |
| Truist Securities | 08 Jan 2026 | 86.00 (7.62%) | 购买 | 73.82 |
| 30 Oct 2025 | 80.00 (0.11%) | 购买 | 63.37 | |
| Morgan Stanley | 06 Jan 2026 | 96.00 (20.14%) | 购买 | 73.99 |
| Leerink Partners | 15 Dec 2025 | 86.00 (7.62%) | 购买 | 74.51 |
| Bernstein | 11 Dec 2025 | 94.00 (17.63%) | 购买 | 74.07 |
| JP Morgan | 07 Nov 2025 | 77.00 (-3.64%) | 购买 | 61.80 |
| HC Wainwright & Co. | 03 Nov 2025 | 90.00 (12.63%) | 购买 | 61.98 |
| 29 Oct 2025 | 90.00 (12.63%) | 购买 | 66.62 | |
| Goldman Sachs | 31 Oct 2025 | 100.00 (25.14%) | 购买 | 62.64 |
| Cantor Fitzgerald | 30 Oct 2025 | 110.00 (37.65%) | 购买 | 63.37 |
| Piper Sandler | 30 Oct 2025 | 98.00 (22.64%) | 购买 | 63.37 |
| Raymond James | 30 Oct 2025 | 71.00 (-11.15%) | 购买 | 63.37 |
| TD Cowen | 30 Oct 2025 | 95.00 (18.88%) | 购买 | 63.37 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合